Chilton Investment Company’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$313K Buy
1,173
+3
+0.3% +$812 0.01% 243
2025
Q4
$294K Buy
1,170
+78
+7% +$20.7K 0.01% 244
2025
Q3
$313K Sell
1,092
-3
-0.3% -$804 0.01% 236
2025
Q2
$287K Buy
1,095
+3
+0.3% +$731 0.01% 194
2025
Q1
$254K Hold
1,092
0.01% 184
2024
Q4
$250K Hold
1,092
0.01% 172
2024
Q3
$244K Hold
1,092
0.01% 181
2024
Q2
$222K Hold
1,092
0.01% 164
2024
Q1
$239K Hold
1,092
0.01% 168
2023
Q4
$248K Hold
1,092
0.01% 155
2023
Q3
$220K Sell
1,092
-371
-25% -$78.3K 0.01% 160
2023
Q2
$303K Buy
+1,463
New +$284K 0.01% 143

Other funds holding LH

Chilton Investment Company's LH Position: Q1 2026 in Review

Chilton Investment Company increased its Labcorp (LH) stake by 0.26% in Q1 2026, buying an estimated $812 and bringing the position to 1,173 shares worth $313K. The position accounts for 0.01% of the portfolio, ranked #243.

Chilton Investment Company first reported a position in LH in Q2 2023 and has held it in 12 quarters since. The position peaked at $313K in Q3 2025. 1,032 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Chilton Investment Company held 1,173 shares of Labcorp worth $313K as of Q1 2026.
  • Chilton Investment Company bought 3 Labcorp shares in Q1 2026, an estimated $812.
  • Labcorp made up 0.01% of Chilton Investment Company's portfolio in Q1 2026, its #243 holding.
  • Chilton Investment Company first reported a position in Labcorp in Q2 2023 and has held it in 12 quarters since.
  • Chilton Investment Company's Labcorp position peaked at $313K in Q3 2025.
  • 1,032 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Chilton Investment Company's 13F filing for Q1 2026, filed 15 May 2026.